Ivermectin Treatment of Livestock for Malaria Control on Sumba Island

松巴岛用伊维菌素治疗牲畜以控制疟疾

基本信息

  • 批准号:
    MR/V004670/1
  • 负责人:
  • 金额:
    $ 31.42万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2021
  • 资助国家:
    英国
  • 起止时间:
    2021 至 无数据
  • 项目状态:
    已结题

项目摘要

Progress against malaria has stalled. New ways to control malaria are urgently needed to aid malaria elimination efforts both globally and in Indonesia. Ivermectin is a drug that can be safely given to humans or animals that makes their blood lethal to Anopheles mosquitoes that transmit malaria. It has been shown in Indonesia that ownership of livestock increases the risk of malaria transmission, and people on Sumba Island keep their livestock underneath their house, potentially attracting more Anopheles and increasing their risk of contracting malaria. We propose to treat livestock with ivermectin and evaluate how effective this is against wild Anopheles on Sumba. This control measure could interrupt the transmission of malaria if deployed on wide scale, and provide benefits of treating worm diseases in the farm animals. Additionally, we will engage the community to demonstrate the potential benefits of treating animals with ivermectin to thwart malaria. We will hold small meetings to gain the community, public health workers, and government officials' perspective on this potential control measure. Understanding the community perspective would allow us to develop the most effective ways to expand and achieve compliance with this control measure on Sumba and other areas of Indonesia. There are many Anopheles species on Sumba and we know very little about their feeding preferences for humans or livestock. We will use both human and livestock baited traps to characterize the feeding behavior of Anopheles on Sumba to gain a better understanding about how effective ivermectin treatment of livestock could be if implemented on Sumba. If positive results shown here, then this intervention could be reproduced throughout Indonesia and other areas of the world to eliminate malaria.
防治疟疾的工作停滞不前。迫切需要控制疟疾的新方法,以帮助全球和印度尼西亚消除疟疾的努力。伊维菌素是一种药物,可以安全地给予人类或动物,使他们的血液致命的按蚊传播疟疾。印度尼西亚的研究表明,拥有牲畜会增加疟疾传播的风险,松巴岛上的人们将牲畜饲养在房屋下面,这可能会吸引更多的按蚊并增加他们感染疟疾的风险。我们建议用伊维菌素治疗牲畜,并评估其对松巴野生按蚊的有效性。如果大规模部署,这种控制措施可以阻断疟疾的传播,并在农场动物中提供治疗蠕虫病的益处。此外,我们将让社区参与,以证明用伊维菌素治疗动物以阻止疟疾的潜在好处。我们将举行小型会议,以了解社区、公共卫生工作者和政府官员对这一潜在控制措施的看法。了解社区的观点将使我们能够制定最有效的方法,在松巴和印度尼西亚其他地区扩大和遵守这一控制措施。松巴岛上有许多按蚊物种,我们对它们对人类或牲畜的摄食偏好知之甚少。我们将使用人类和牲畜诱饵陷阱来描述Sumba上按蚊的摄食行为,以更好地了解如果在Sumba上实施伊维菌素治疗牲畜的有效性。如果这里显示出积极的结果,那么这种干预措施可以在印度尼西亚和世界其他地区复制,以消除疟疾。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lorenz Von Seidlein其他文献

Characterisation of between-cluster heterogeneity in malaria cluster randomised trials to inform future sample size calculations
疟疾整群随机试验中群间异质性的特征描述,以指导未来的样本量计算
  • DOI:
    10.1038/s41467-025-61502-w
  • 发表时间:
    2025-07-18
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Joseph Biggs;Joseph D. Challenger;Dominic Dee;Eldo Elobolobo;Carlos Chaccour;Francisco Saute;Sarah G. Staedke;Sibo Vilakati;Jade Benjamin Chung;Michelle S. Hsiang;Edgard Diniba Dabira;Annette Erhart;Umberto D’Alessandro;Rupam Tripura;Thomas J. Peto;Lorenz Von Seidlein;Mavuto Mukaka;Jacklin Mosha;Natacha Protopopoff;Manfred Accrombessi;Richard Hayes;Thomas S. Churcher;Jackie Cook
  • 通讯作者:
    Jackie Cook

Lorenz Von Seidlein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lorenz Von Seidlein', 18)}}的其他基金

MICA: An evaluation of the antimalarial vaccine candidateR21/matrix M for malaria elimination strategy in the Greater Mekong Subregion
MICA:针对大湄公河次区域疟疾消除战略的抗疟候选疫苗 R21/matrix M 的评估
  • 批准号:
    MR/T04473X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Research Grant
Roll out the radical cure with primaquine for vivax elimination: development grant
推出伯氨喹消除间日疟的根治方法:发展补助金
  • 批准号:
    MR/T003553/1
  • 财政年份:
    2020
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Research Grant

相似海外基金

Development of Teat-Dipping Nanoemulsion Loaded with Curcumin for Prevention of Intramammary Infection and Treatment of Mastitis as an Immune Stimulant
开发含有姜黄素的乳头浸渍纳米乳作为免疫兴奋剂预防乳房内感染和治疗乳腺炎
  • 批准号:
    24K09263
  • 财政年份:
    2024
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SBIR Phase II: A mesh-free, sling-free, minimally invasive treatment for stress urinary incontinence in women
SBIR II 期:无网、无吊带的微创治疗女性压力性尿失禁
  • 批准号:
    2233106
  • 财政年份:
    2024
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Cooperative Agreement
Catalyzing Sustainable Air Travel: Unveiling Consumer Willingness to Pay for Sustainable Aviation Fuel through Information Treatment in Choice Experiment and Cross-Country Analysis
促进可持续航空旅行:通过选择实验和跨国分析中的信息处理揭示消费者支付可持续航空燃油的意愿
  • 批准号:
    24K16365
  • 财政年份:
    2024
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Role of CA8 in Hepatic Glucose Production and Its Prospect as Type 2 Diabetes Mellitus Treatment
CA8在肝葡萄糖生成中的作用及其治疗2型糖尿病的前景
  • 批准号:
    24K19287
  • 财政年份:
    2024
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Machine Learning for Computational Water Treatment
用于计算水处理的机器学习
  • 批准号:
    EP/X033244/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Research Grant
BOOSTING SEMICONDUCTORS: FOR PHOTOCATALYTIC WATER TREATMENT (BO-SE)
升压半导体:用于光催化水处理 (BO-SE)
  • 批准号:
    EP/Y003063/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Research Grant
An innovative urinary drainage system that could reduce NHS CAUTI treatment costs by 10% and increase quality-of-life for men suffering from chronic incontinence
%20创新%20泌尿%20引流%20系统%20%20可以%20减少%20NHS%20CAUTI%20治疗%20成本%20by%2010%%20和%20增加%20生活质量%20为%20男性%20痛苦%20来自%20慢性%20失禁
  • 批准号:
    10094849
  • 财政年份:
    2024
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Collaborative R&D
SpyTCR-RBNP - Engineering a highly targeted and biocompatible drug delivery system for solid cancer treatment
SpyTCR-RBNP - 设计用于实体癌症治疗的高度针对性和生物相容性的药物输送系统
  • 批准号:
    10095606
  • 财政年份:
    2024
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Collaborative R&D
Validating FilaChar Use in Wastewater Treatment
验证 FilaChar 在废水处理中的使用
  • 批准号:
    10106623
  • 财政年份:
    2024
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Launchpad
Repurposing flumazenil for pre-hospital intramuscular treatment of coma due to recreational drug overdose
重新利用氟马西尼用于院前肌肉注射治疗因娱乐性药物过量而导致的昏迷
  • 批准号:
    MR/X030237/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.42万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了